Principal Investigator/Program Director (last, first, middle) 
R " BIOGRAPHICAL SKETCH 
Give the following information for the key personnel, consultants, and collaborators. Begin with the principal 
ble investigator/program director. Photocopy this page for each person. 
i of 
39 . 
cts 
P, 
pie 
iol. 
ith 
eal 
ant 
)n, 
ms 
o„ 
as. 
jy. 
1Y. 
<ic 
od 
on 
ise 
sal 
am 
13 ) 
ise 
:ed 
13 . 
ge 
DiC 
ra, 
• 2 , 
ble 
NAME 
POSITION TITLE 
Peter A. Cassileth, M.D. 
Professor of Medicine 
EDUCATION (Begin with baccalaureate or other initial professional education, such as nursing, and include postdoctoral training.) 
INSTITUTION AND LOCATION 
DEGREE 
YEAR 
CONFERRED 
HELD OF STUDY 
Union College, Schenectady, N.Y. 
B.A. 
1958 
English 
Columbia University College of 
M.D. 
1962 
Medicine 
Physicians and Surgeons 
RESEARCH AND PROFESSIONAL EXPERIENCE: Concluding with present position, list in chronological order previous employment, experience, 
and honors. Key personnel include the principal investigator and any other individuals who participate in the scientific development or execution of 
the project. Key personnel typically will include all individuals with doctoral or other professional degrees, but in some projects will include individuals 
at the masters or baccalaureate level provided they contribute in a substantive way to the scientific development or execution of the project. Include 
present membership on any Federal Government Public Advisory Committee. List, in chronological order, the titles, all authors, and complete 
references to all publications during the past three years and to representative earlier publications pertinent to this application. IX) NOT EXCEED 
TWO PAGES. 
PREVIOUS EMPLOYMENT/EXPERIENCE: 
1962- 63 Intern in Medicine, Columbia-Presbyterian Medical Center, N.Y.C. 
1963- 65 Resident in Medicine, Columbia-Presbyterian Medical Center, N.Y.C. 
1965- 66 Fellow in Hematology, Columbia-Presbyterian Medical Center, N.Y.C. 
1966 Chief Resident in Medicine, Delafield Cancer Hospital, Columbia-Presbyterian Medical Center, N.Y.C. 
1968- 69 Fellow in Hematology, Columbia-Presbyterian Medical Center, N.Y.C. 
1966- 68 Hematologist/Oncologist, Ireland Army Hospital, Fort Knox, KY 
1969- 75 Assistant Professor of Medicine, Department of Medicine, University of Pennsylvania 
1975-79 Associate Professor of Medicine, Department of Medicine, University of Pennsylvania 
1979-92 Professor of Medicine, Department of Medicine, University of Pennsylvania 
1992- Professor of Medicine, Department of Medicine, University of Miami 
1992- Chief, Division of Hematology/Oncology, University of Miami 
1992- Director, Bone Marrow Transplantation Program, University of Miami 
HONORS: 1958 Phi Beta Kappa 
1961 Alpha Omega Alpha 
SELECTED PUBLICATIONS: (N = 98) 
1. Spiers, A.S.D., Moore, D., Cassileth. P.A.. Harrington, D.P., Cummings, F.J., Neiman, R.S., Bennett, J.M. and 
O’Connell, M.J.: Remissions in hairy-cell leukemia with pentostatin (2'-deoxycoformycin). N. Engl. J. Med. 
316:825-830, 1987. 
2. Talbot, G.J., Provencher, M. and Cassileth. P.A. : Persistent fever after recovery from granulocytopenia in acute 
leukemia. Arch. Intern. Med. 148:129-135, 1988. 
3. Cassileth. P.A. . Struhar, S.L., Bennett, J.M. and Begg, C.B.: High peripheral blast count in adult acute myelogenous 
leukemia is a primary risk factor for central nervous system leukemia. J. Clin. Oncol. 6: 495-498, 1988. 
4. Cassileth. PA. . Harrington, D.P., Hines, J.D., Oken, M.M., Mazza, J.J., McGlave, P„ Bennett, J.M. and O’Connell, 
M.J.: Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia. J. Clin. 
Oncol. 6:583-587, 1988. 
5. B dwell, B.J., Cassileth. P A. and Gale, R.P.: High dose cytarabine: A review. Leukemia 2:253-260, 1988. 
6. Stewart, J.A., Cassileth. PA. . Bennett, J.M. and O’Connell, M.J.: Continuous infusion homoharringtonine (NSC 
141633) in refractory acute nonlymphocytic leukemia. Amer. J. Clin. Oncol. 11:627-629, 1988. 
7. Bennett, J.M., Miller, K.B., Kyungmann, K., Morrison, F.S., Winter, J.N., Cassileth. P.A., Neiman, R.S. and Head, 
D.: Phase III evaluation of low dose ARA-C versus supportive care in the treatment of adults with the 
myelodysplastic syndrome: an intergroup study by the Eastern Cooperative Oncology Group (ECOG) and the South 
Western Oncology Group (SWOG): in First International Symposium on Mvelodvsplastic Syndromes. Springer 
International, Berlin, 1988. 
PHS 398 (Rev. 9/91) (Form Page 6) Page . 
Humber 18 ' “ 3a ' 3b 
[ 269 ] 
